Comparative efficacy and safety of antiplatelet or anticoagulant therapy in patients with chronic coronary syndromes after percutaneous coronary intervention: A network meta-analysis of randomized controlled trials

Comparative efficacy and safety of antiplatelet or anticoagulant therapy in patients with chronic coronary syndromes after percutaneous coronary intervention: A network meta-analysis of randomized controlled trials

Aimed to evaluate and compare the interactive effects of different antiplatelet or anticoagulation strategies in patients with chronic coronary syndromes (CCS) after percutaneous coronary intervention (PCI). Randomized controlled trials comparing different antiplatelet or anticoagulant strategies in...

Full description

Bibliographic Details
Main Authors: Yaowang Lin, Zhigang Cai, Shaohong Dong, Huadong Liu, Xinli Pang, Qiuling Chen, Jie Yuan, Qingshan Geng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Pharmacology
Subjects:
antiplatelet therapy
chronic coronary syndromes
percutaneous coronary intervention
randomized control trials
geriatric disease
anticoagulant
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.992376/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.992376/full

Similar Items